Photodynamic therapy should be considered for the treatment of folliculitis decalvans

Lun Yang,Jing Chen,Xiaoliang Tong,Lihua Gao,Shu Ding,Aiyuan Guo
DOI: https://doi.org/10.1016/j.pdpdt.2021.102356
IF: 3.577
2021-09-01
Photodiagnosis and Photodynamic Therapy
Abstract:<p><strong>Background:</strong> Different therapies such as clindamycin, rifampicin, isotretinoin, or corticosteroids have been used for folliculitis decalvans with poor results. Recently, PDT has been used for treating folliculitis decalvans more frequently. However, the efficacy of PDT for treating folliculitis decalvans is lacking consensus. In this study, we conducted a retrospective analysis to evaluated the status of PDT for the treatment of folliculitis decalvans.</p><p><strong>Methods:</strong> 13 cases of folliculitis decalvans patients were treated with ALA-PDT. The treatment totals 3 times, and the interval between each treatment was 10–14 days. A follow-up was conducted at 12 months after the last treatment. The condition was graded according to the following evaluation criteria: recovery, significant improvement, moderate improvement, ineffective.</p><p><strong>Results:</strong> A total of 7 cases improved significantly, and 6 cases improved moderately followed the first treatment. After the second treatment, 10 cases showed significant improvement, and 2 cases responded poorer than the first treatment. After the third treatment, 4 cases recovered, 7 cases improved significantly, and 2 case moderately improved. At the 12-months follow-up, 9 out of 13 patients were well controlled and with no recurrence. The other 4 patients relapsed.</p><p><strong>Conclusion:</strong> In summary, photodynamic therapy shows overall favorable effect on folliculitis decalvans and should be considered as a  method for the treatment of folliculitis decalvans.</p>
oncology
What problem does this paper attempt to address?
The paper mainly explores the application effect of Photodynamic Therapy (PDT) in the treatment of folliculitis decalvans (FD). Folliculitis decalvans is a rare and destructive inflammatory scalp disease characterized by pain, recurrent pustules, and crusting, ultimately leading to permanent scarring alopecia. Although various treatments such as oral antibiotics and topical medications have been used to treat folliculitis decalvans, the efficacy is not ideal, and relapses are common. The paper mentions that in recent years, photodynamic therapy, as a new treatment method, has shown certain application potential in the treatment of folliculitis decalvans. However, the research results on its efficacy are inconsistent; some studies show that photodynamic therapy is effective, while others report ineffectiveness or worsening of the condition. Therefore, the researchers conducted a retrospective analysis to evaluate the actual effect of photodynamic therapy in the treatment of folliculitis decalvans. The study included a total of 13 patients, all treated with 5-aminolevulinic acid photodynamic therapy (ALA-PDT). Each patient received 3 treatments, with each treatment interval being 10-14 days. The results showed that most patients experienced symptom improvement after treatment, with some patients achieving significant improvement or even complete recovery. After 12 months of follow-up, the condition of 9 patients was effectively controlled without recurrence, while the remaining 4 patients experienced a relapse. In conclusion, the study indicates that photodynamic therapy has a generally good therapeutic effect on folliculitis decalvans and can be considered an alternative treatment for refractory folliculitis decalvans. However, due to the small sample size, more case studies and randomized controlled trials are needed to further verify the efficacy and safety of photodynamic therapy.